CD146+CAFs mediate immunosuppression in gastric cancer via COL4A1: potential therapeutic targets
Jia Chen, Peng Xu, Qingyuan Wang, Juncheng Dai, Shuang Liang, Sheng Yang, Guiping Xie, Xiang Li, Yaohui Wang, Hongjin Hua, Xiaochun Ping, Jiajia Shen, Lizong Shen · 2025
Read CD146+CAFs mediate immunosuppression in gastric cancer via COL4A1: potential therapeutic targets by Jia Chen, Peng Xu, Qingyuan Wang, Juncheng Dai, Shuang Liang, Sheng Yang, Guiping Xie, Xiang Li, Yaohui Wang, Hongjin Hua, Xiaochun Ping, Jiajia Shen, Lizong Shen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12718570.txt.
Description
Jia Chen, Peng Xu, and their co-authors identified a subset of tumor support cells that helps gastric cancer hide from the immune system. Their 2025 study concerns cancer associated fibroblasts, the scaffold cells around a tumor. Which subtypes suppress immunity, and how, was not well mapped.
The team built a protocol to enrich fibroblasts from stomach tumors and matched healthy tissue, then sequenced 8,322 cells from nine patient pairs, one cell at a time. A subset marked by the protein CD146 stood out. It was enriched in tumors, linked to poor survival, and sat with macrophage cells of a suppressive type. Tumor cells fed its growth through two signal routes. The subset acts through a collagen gene, COL4A1, which the authors name as a possible drug target.
Catalog record
| CREATOR | Jia Chen, Peng Xu, Qingyuan Wang, Juncheng Dai, Shuang Liang, Sheng Yang, Guiping Xie, Xiang Li, Yaohui Wang, Hongjin Hua, Xiaochun Ping, Jiajia Shen, Lizong Shen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |